Advancing Chemokine GPCR Structure Based Drug Discovery

doi:10.1016/j.str.2019.02.004

	Advancing Chemokine GPCR Structure Based Drug Discovery
	Zhao, Suwen 1,2; Wu, Beili 3,4; Stevens, Raymond C.1,2
刊名	STRUCTURE
	2019-03-05
卷号	27 期号:3 页码:405-408
ISSN号	0969-2126
DOI	10.1016/j.str.2019.02.004
通讯作者	Stevens, Raymond C.()
英文摘要	In this issue of Structure, Apel et al., (2019) provide structural insight into the inhibition of a human chemokine G-protein-coupled receptor by a small-molecule antagonist, which advances our understanding of drug design principles for this complex family of receptors.
WOS关键词	CXCR4
WOS研究方向	Biochemistry & Molecular Biology ; Biophysics ; Cell Biology
语种	英语
出版者	CELL PRESS
WOS记录号	WOS:000460258100001
内容类型	期刊论文
源URL	[http://119.78.100.183/handle/2S10ELR8/290341]
专题	中国科学院上海药物研究所
通讯作者	Stevens, Raymond C.
作者单位	1.ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China 2.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China 4.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
推荐引用方式 GB/T 7714	Zhao, Suwen,Wu, Beili,Stevens, Raymond C.. Advancing Chemokine GPCR Structure Based Drug Discovery[J]. STRUCTURE,2019,27(3):405-408.
APA	Zhao, Suwen,Wu, Beili,&Stevens, Raymond C..(2019).Advancing Chemokine GPCR Structure Based Drug Discovery.STRUCTURE,27(3),405-408.
MLA	Zhao, Suwen,et al."Advancing Chemokine GPCR Structure Based Drug Discovery".STRUCTURE 27.3(2019):405-408.